SALOME SOTO: Open Payments
NPI 1720576481 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,675 in 105 payments from 20 companies in 2025. Trend: 2023 $2,427 · 2024 $2,437 · 2025 $2,675
Food & beverage: $2,675
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 28 | $567 |
| Alnylam Pharmaceuticals Inc. | 7 | $279 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $243 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $214 |
| CVRx, Inc. | 3 | $205 |
| E.R. Squibb & Sons, L.L.C. | 3 | $169 |
| Novartis Pharmaceuticals Corporation | 17 | $166 |
| Merck Sharp & Dohme LLC | 6 | $122 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $113 |
| Lilly USA, LLC | 1 | $111 |
Products named: Repatha, JARDIANCE, Kerendia, Barostim Neo System, LEQVIO, AMVUTTRA, CAMZYOS, ONPATTRO.
Industry payments across CA — which companies pay providers there.
